Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
e developed by eTUMOUR is likely to become a powerful<br />
tool for accurate diagnosis, prognosis and treatment selection<br />
and monitoring. The development of a web-based<br />
decision support system is innovative in itself and will promote<br />
the concept of how a multi-centre, web-distributed<br />
database of clinical information can be accessed, used and<br />
updated within healthcare systems with their unique and<br />
stringent constraints of data security and privacy. New criteria<br />
for classifying brain tumours will arise from eTUMOUR by<br />
determining the metabolomic and genomic profi les of<br />
tumours and relating these to prognosis and treatment<br />
response. Particularly signifi cant will be the DNA microarray<br />
data, which may suggest the most appropriate genes to be<br />
used as markers for tumour classifi cation and may lead to<br />
development of new or customised microarrays for routine<br />
clinical use. Genomic and metabolomic data is complementary<br />
to standard WHO pathological classifi cations. The<br />
combined molecular and clinical data is likely to produce<br />
a new and more complete methodology for classifi cation<br />
and grading of all types of tumours and should also increase<br />
our understanding of tumour biology and its variation.<br />
Coordinator<br />
Bernardo Celda<br />
University of Valencia<br />
Dept. of Physical Chemistry<br />
Valencia, Spain<br />
bernardo.celda@uv.es<br />
Partners<br />
Carles Arús<br />
Universitat Autònoma de Barcelona<br />
Unitat de Ciències<br />
Departament de Bioquímica<br />
i Biologia Molecular<br />
Bellaterra, Spain<br />
carles.arus@uab.es<br />
Franklyn Arron Howe<br />
St George’s Hospital Medical School<br />
Basic Medical Sciences<br />
London, United Kingdom<br />
howefa@sghms.ac.uk<br />
Arend Heerschap<br />
University Medical Center Nijmegen<br />
Nijmegen, The Netherlands<br />
a.heerschap@rad.umcn.nl<br />
Lutgarde Buydens<br />
Stichting Katholieke Universiteit<br />
Dept. of Analytical Chemistry<br />
Nijmegen, The Netherlands<br />
l.buydens@sci.kun.nl<br />
130<br />
Christoph Segebarth<br />
Unité Mixte INSERM<br />
Université Joseph Fourier U594<br />
Neuroimagerie Fonctionnelle<br />
et Métabolique<br />
Grenoble, France<br />
christoph.segebarth@ujf-grenoble.fr<br />
Magí Lluch<br />
MICROART, S.L.<br />
Barcelona.,Spain<br />
mlluch@microart.es<br />
Antoni Capdevila<br />
Hospital San Joan de Deu<br />
Esplugues de Llobregat, Spain<br />
acapdevila@hsjdbcn.org<br />
Gilda D’Incerti<br />
Pharma Quality Europe, s.r.l.<br />
Florence, Italy<br />
g.dincerti@pqe.it<br />
Luigi Visani<br />
Hyperphar Group SpA.<br />
Milan, Italy<br />
lvisani@hyperphar.it<br />
Sabine van Huffel<br />
Katholieke Universiteit Leuven<br />
<strong>Research</strong> and Development<br />
Leuven, Belgium<br />
sabine.vanhuffel@esat.kuleuven.ac.be<br />
Peter Kreisler<br />
Siemens AG, Medical Solutions<br />
Erlangen, Germany<br />
stefan.roell@siemens.com<br />
Arno Klaassen<br />
Scito S.A.<br />
Grenoble, France<br />
arno@scito.com<br />
Montserrat Robles<br />
Universidad Politécnica de Valencia<br />
Valencia, Spain<br />
mrobles@fis.upv.es<br />
Semmler Wolfhard<br />
Deutsche Krebsforschungszentrum<br />
Heidelberg<br />
Heidelberg, Germany<br />
Wolfhard.Semmler@dkfz.de<br />
Martial Piotto<br />
Bruker Biospin SA.<br />
Wissembourg, France<br />
martial.piotto@bruker.fr<br />
Richard Grundy<br />
Institute of Child Health<br />
University of Birmingham<br />
Birmingham, United Kingdom<br />
r.g.grundy@bham.ac.uk<br />
Project number<br />
LSHC-CT-2004-503094<br />
EC contribution<br />
€ 7 499 982<br />
Duration<br />
60 months<br />
Starting date<br />
01/02/2004<br />
Instrument<br />
IP<br />
Project website<br />
www.uv.es/etumour<br />
www.etumour.net<br />
François Berger<br />
INSERM U318<br />
Grenoble, France<br />
francois.berger@ujf-grenoble.fr<br />
Jorge Calvar<br />
Fundación para la Lucha contra<br />
Enfermedades Neurológicas de la Infancia<br />
Buenos Aires, Argentina<br />
jcalvar@fleni.org.ar<br />
Witold Gajewicz<br />
Medical University Lodz<br />
Lodz, Poland<br />
gajewicz@onet.pl<br />
CANCER RESEARCH PROJECTS FUNDED UNDER THE SIXTH FRAMEWORK PROGRAMME
Change language